Lv1
50 积分 2025-04-05 加入
Breaking the therapeutic ceiling in drug development in ulcerative colitis
9小时前
待确认
What Is Ulcerative Colitis?
10小时前
已完结
Empowering AI data scientists using a multi-agent LLM framework with self-evolving capabilities for autonomous, tool-aware biomedical data analyses
2个月前
已完结
Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites
5个月前
已完结
Non‐oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically
6个月前
已完结
Eosinophilic Gastroenteritis: An Underdiagnosed Condition
6个月前
已完结
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
7个月前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
7个月前
已完结
皖公网安备34019202002308
